| Dr Dracina Wood, MD | |
|
2020 Meridian St Ste 220, Anderson, IN 46016-4338 | |
| (765) 683-3158 | |
| Not Available |
| Full Name | Dr Dracina Wood |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 2020 Meridian St Ste 220, Anderson, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134417116 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 01075319A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent Anderson | Anderson, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
Goethe University Frankfurt develops OECD test with the freshwater mudsnail. Regulatory authorities around the world can in future instruct manufacturers of chemicals and drugs to check their products for harmful effects on reproduction by means of a new test with molluscs.
As a surgeon performs a minimally invasive procedure at Cedars-Sinai Medical Center in Los Angeles, surgeons observing in Boston or Mexico City or London will notice a remarkable improvement in clarity, compared to the view they would have had in the past.
The Medicines for Malaria Venture (MMV) today became the first product development partnership (PDP) to contribute intellectual property to the Pool for Open Innovation against Neglected Tropical Diseases. MMV joins GlaxoSmithKline (GSK), Alnylam Pharmaceuticals, and the Massachusetts Institute of Technology (MIT) in contributing to the Pool, which is administered by BIO Ventures for Global Health (BVGH).
Through a $300,000 grant from Administration of Children and Families, part of Department of Health and Human Services, Debra Zand, Ph.D., associate professor of pediatrics at Saint Louis University, will study treatment services offered by a local community provider to St. Louis area women who abuse illegal substances, and for their infants and toddlers.
A study by researchers in the Royal College of Surgeons in Ireland (RCSI) has uncovered a potential new target for the treatment of a range of intestinal diseases that are associated with diarrhoea. Current medications are often ineffective and can have serious side effects so this discovery gives hope for the development of new treatments for sufferers of intestinal disease.
› Verified 6 days ago
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
Goethe University Frankfurt develops OECD test with the freshwater mudsnail. Regulatory authorities around the world can in future instruct manufacturers of chemicals and drugs to check their products for harmful effects on reproduction by means of a new test with molluscs.
As a surgeon performs a minimally invasive procedure at Cedars-Sinai Medical Center in Los Angeles, surgeons observing in Boston or Mexico City or London will notice a remarkable improvement in clarity, compared to the view they would have had in the past.
The Medicines for Malaria Venture (MMV) today became the first product development partnership (PDP) to contribute intellectual property to the Pool for Open Innovation against Neglected Tropical Diseases. MMV joins GlaxoSmithKline (GSK), Alnylam Pharmaceuticals, and the Massachusetts Institute of Technology (MIT) in contributing to the Pool, which is administered by BIO Ventures for Global Health (BVGH).
Through a $300,000 grant from Administration of Children and Families, part of Department of Health and Human Services, Debra Zand, Ph.D., associate professor of pediatrics at Saint Louis University, will study treatment services offered by a local community provider to St. Louis area women who abuse illegal substances, and for their infants and toddlers.
A study by researchers in the Royal College of Surgeons in Ireland (RCSI) has uncovered a potential new target for the treatment of a range of intestinal diseases that are associated with diarrhoea. Current medications are often ineffective and can have serious side effects so this discovery gives hope for the development of new treatments for sufferers of intestinal disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dracina Wood, MD 2020 Meridian St Ste 220, Anderson, IN 46016-4338 Ph: () - | Dr Dracina Wood, MD 2020 Meridian St Ste 220, Anderson, IN 46016-4338 Ph: (765) 683-3158 |
News Archive
Goethe University Frankfurt develops OECD test with the freshwater mudsnail. Regulatory authorities around the world can in future instruct manufacturers of chemicals and drugs to check their products for harmful effects on reproduction by means of a new test with molluscs.
As a surgeon performs a minimally invasive procedure at Cedars-Sinai Medical Center in Los Angeles, surgeons observing in Boston or Mexico City or London will notice a remarkable improvement in clarity, compared to the view they would have had in the past.
The Medicines for Malaria Venture (MMV) today became the first product development partnership (PDP) to contribute intellectual property to the Pool for Open Innovation against Neglected Tropical Diseases. MMV joins GlaxoSmithKline (GSK), Alnylam Pharmaceuticals, and the Massachusetts Institute of Technology (MIT) in contributing to the Pool, which is administered by BIO Ventures for Global Health (BVGH).
Through a $300,000 grant from Administration of Children and Families, part of Department of Health and Human Services, Debra Zand, Ph.D., associate professor of pediatrics at Saint Louis University, will study treatment services offered by a local community provider to St. Louis area women who abuse illegal substances, and for their infants and toddlers.
A study by researchers in the Royal College of Surgeons in Ireland (RCSI) has uncovered a potential new target for the treatment of a range of intestinal diseases that are associated with diarrhoea. Current medications are often ineffective and can have serious side effects so this discovery gives hope for the development of new treatments for sufferers of intestinal disease.
› Verified 6 days ago
Carol A Clark, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1130 Medical Arts Blvd, Suite 250, Anderson, IN 46011 Phone: 765-298-4282 Fax: 765-298-4989 | |
Jennifer Nemunaitis Keller, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1130 Medical Arts Blvd Ste 250, Anderson, IN 46011 Phone: 765-298-4282 | |
Dr. Joseph Conrad Copeland, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1210 Medical Arts Blvd, #315, Anderson, IN 46011 Phone: 765-298-4020 Fax: 765-298-4930 | |
Raja Sekar Mittapalli, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1130 Medical Arts Blvd Ste 250, Anderson, IN 46011 Phone: 765-298-4282 Fax: 765-298-4989 | |
Susan T Mitchell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2020 Meridian St Ste 220, Anderson, IN 46016 Phone: 765-683-3280 | |
Jeffrey M Blake, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 309, Anderson, IN 46016 Phone: 765-646-8569 |